GlassScriptPhysician profile
Ashley C Sellechio
NPI 1750865630
$3,340.62
in general payments reported to CMS, 2019-2025
18 companies · $2,961 in 2025
The $2,961 reported for 2025 was more than what 95% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $102 · 2023: $104 · 2024: $173 · 2025: $2,961.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,960 · Travel and Lodging: $248 · Education: $31.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,959.73 |
| Travel and Lodging | $247.75 |
| Education | $31.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $504.29 | 2025 | Cardiomems |
| Bayer Healthcare Pharmaceuticals INC. | $482.01 | 2022-2025 | |
| Impulse Dynamics (USA) INC. | $474.90 | 2025 | Optimizer |
| United Therapeutics Corporation | $402.27 | 2024-2025 | Tyvaso, Tyvaso, Orenitram |
| Alnylam Pharmaceuticals INC. | $231.98 | 2024-2025 | Onpattro, Amvuttra |
| Scpharmaceuticals INC. | $173.15 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $171.97 | 2025 | Verquvo, Winrevair, Capvaxive |
| Shockwave Medical, INC | $170.38 | 2025 | |
| Pfizer INC. | $166.59 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $162.86 | 2025 | Lifevest |
| Corcept Therapeutics | $103.88 | 2023 | Korlym |
| Astrazeneca Pharmaceuticals LP | $80.66 | 2025 | Farxiga, Wainua |
| E.R. Squibb & Sons, L.L.C. | $68.05 | 2025 | Camzyos |
| Actelion Pharmaceuticals US, INC. | $52.28 | 2025 | Uptravi |
| Novartis Pharmaceuticals Corporation | $42.17 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $20.35 | 2025 | Attruby |
| Boston Scientific Corporation | $19.23 | 2025 | Watchman Flx |
| Kestra Medical Technology Services, INC. | $13.60 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Sellechio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.